AFT

AFT Pharmaceuticals Limited - Announcements

0.73%

$2.77

Healthcare Biotechnology

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AFT	AFT notes Maxigesic® sales estimates in new market research		113.6KB	Share
AFT	Amended Capital Change Notice		135.57KB	Share
AFT	Capital Change Notice - Issue of ordinary shares		135.43KB	Share
AFT	AFT secures Maxigesic® IV distribution in Indonesia		138.87KB	Share
AFT	AFT welcomes new codeine medicine restrictions		157.72KB	Share
AFT	Maxigesic to launch in Canada in 2020		148.39KB	Share
AFT	Condensed consolidated interim financial statements	PRICE SENSITIVE	307.69KB	Share
AFT	AFT earnings rise in line with guidance	PRICE SENSITIVE	296.58KB	Share
AFT	AFT signs agreements to new markets worth more than US$1bil		174.16KB	Share
AFT	AFT to book one-off non-cash gain on Pascomer® assets	PRICE SENSITIVE	117.44KB	Share
AFT	AFT to announce half year results on Nov 21 '19		96.15KB	Share
AFT	AFT and SETEK sign medicinal cannabis MoU		175.7KB	Share
AFT	Amended Constitution		346.28KB	Share
AFT	Annual Meeting Results		235.4KB	Share
AFT	Annual Shareholders Meeting Address and Presentation	PRICE SENSITIVE	3.03MB	Share
AFT	Maxigesic IV registration in Australia		120.36KB	Share
AFT	AFT Licensing Agreement for Pascomer® in North America	PRICE SENSITIVE	158.36KB	Share
AFT	Notice of Annual Meeting of Shareholders 2019		282.56KB	Share
AFT	AFT Pharmaceuticals’ completes first deal in South America		145.41KB	Share
AFT	Annual Meeting and Closing Date for Director Nominations		145.29KB	Share
AFT	FY2019 Annual Report	PRICE SENSITIVE	3.51MB	Share
AFT	AFT Pharmaceuticals establishes new borrowing facilities	PRICE SENSITIVE	120.95KB	Share
AFT	AFT Pharmaceuticals poised for strong earnings growth	PRICE SENSITIVE	157.27KB	Share
AFT	AFT results announcement May 22 2019		151.65KB	Share
AFT	Clarification		179.89KB	Share
AFT	AFT Pharmaceuticals’ completes another 3 deals		495.25KB	Share
AFT	Transition to new NZX listing rules wef 1 April 2019		79.23KB	Share
AFT	AFT Completes Successful Development of Maxigesic Rapid		111.25KB	Share
AFT	2019 New Year Letter to Investors		120.62KB	Share
AFT	Waiver from NZX Main Board Listing Rule 5.2.3		396.31KB	Share
AFT	Ongoing Disclosure Notice		65.48KB	Share
AFT	New trial of MAXIGESIC® pain relief published in major int		133.85KB	Share
AFT	narrative correct on page 18 of the Interim Report		452.37KB	Share
AFT	FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2018	PRICE SENSITIVE	224.01KB	Share
AFT	AFT starts to license Maxigesic IV with deal in South Korea		88.86KB	Share
AFT	AFT to announce half year results on Thursday Nov 22 2018		24.22KB	Share
AFT	Maxigesic is now licensed in the Russian Federation	PRICE SENSITIVE	50.61KB	Share
AFT	section 297(2) 298(2) Directors Interests		60.02KB	Share
AFT	AFT Annual Meeting Results 2018		255.21KB	Share
AFT	AFT Annual Meeting 2018 Presentation	PRICE SENSITIVE	661.78KB	Share
AFT	Chairman's Address at AFT Annual Meeting	PRICE SENSITIVE	298.42KB	Share
AFT	Meeting of Shareholders 2018 proxy		133.21KB	Share
AFT	Notice of Annual Meeting of Shareholders 2018		265.2KB	Share
AFT	Annual Report	PRICE SENSITIVE	3.73MB	Share
AFT	NOTICE PURSUANT TO LISTING RULE 7.12.1		63.8KB	Share
AFT	Annual Report FY2018	PRICE SENSITIVE	3.73MB	Share
AFT	Annual Meeting and Closing Date for Director Nominations		105.8KB	Share
AFT	AFT FY2018 Results Announcement	PRICE SENSITIVE	165.65KB	Share
AFT	AFT Pharmaceuticals Update		22.82KB	Share
AFT	AFT Divests Non-Core Products to Focus on Key Products	PRICE SENSITIVE	120.99KB	Share
AFT	Maxigesic hits No. 1 in key Australian painkiller marke		112.35KB	Share
AFT	Notice to shareholders – Change of auditor		38.29KB	Share
AFT	Prescription-only codeine medicines in New Zealand welcomed		46.05KB	Share
AFT	AFT painkiller Maxigesic now licensed in Mexico		45.71KB	Share
AFT	Waiver from NZX Main Board Listing Rule 5.2.3		266.16KB	Share
AFT	FY2018 H1 Updated Presentation		2.3MB	Share
AFT	FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2017	PRICE SENSITIVE	168.32KB	Share
AFT	Results for announcement to the market App1	PRICE SENSITIVE	107.46KB	Share
AFT	Interim Report FY2018	PRICE SENSITIVE	852.02KB	Share
AFT	FY2018 H1 Update Presentation	PRICE SENSITIVE	2.3MB	Share
AFT	to announce half year results on Thursday November 23 2017		25.05KB	Share
AFT	Positive result from large US clinical trial for Maxigesic		50.01KB	Share
AFT	170929 Market Update		34.34KB	Share
AFT	170928 AFT Pharmaceuticals Presentation ASX		2.27MB	Share
AFT	AFT Pharmaceuticals celebrates 20 years of success		49.81KB	Share
AFT	NZSA presentation		2.45MB	Share
AFT	AFT supports Commerce Commission recommendations		43.68KB	Share
AFT	Resignation of Head of International Business and Business		51.68KB	Share
AFT	Annual Meeting Results 2017		39.87KB	Share
AFT	2017 Annual Meeting Presentations	PRICE SENSITIVE	64.39KB	Share
AFT	AFTpainkiller Maxigesic now licensed in 124 countries		71.66KB	Share
AFT	AFT Notice of Annual Meeting of Shareholders 2017		409.44KB	Share
AFT	D&O Ongoing Disclosure for James Burns		70.04KB	Share
AFT	D&O Ongoing Disclosure for James Burns		94.51KB	Share
AFT	AFT SPP 7.12.1 Notice		71.65KB	Share
AFT	D&O Ongoing Disclosure - multiple Directors		68.5KB	Share
AFT	Successful share purchase plan for AFT Pharmaceuticals		94.41KB	Share
AFT	s 209 notice		285.73KB	Share
AFT	Issue of Annual Report to security holders	PRICE SENSITIVE	1.78MB	Share
AFT	Annual Meeting and Closing Date for Director Nominations		105.58KB	Share
AFT	Ongoing Disclosure Notice - John Douglas Wilson		67.54KB	Share
AFT	SPH Notice - AFT Pharmaceuticals Limited		17.85KB	Share
AFT	Share Purchase Plan Opens	PRICE SENSITIVE	98.9KB	Share
AFT	Cleansing Notice		42.66KB	Share
AFT	AFT FY2017 Results Announcement	PRICE SENSITIVE	203.17KB	Share
AFT	Maxigesic now licensed in France	PRICE SENSITIVE	47.69KB	Share
AFT	Further European approvals for Maxigesic		49.77KB	Share
AFT	Maxigesic on track to access the large United States market		99.77KB	Share
AFT	AFT Pharm to announce full year on Wednesday May 24		24.85KB	Share
AFT	AFT Pharmaceuticals Presentation - Woodward partners NZ mid		946.78KB	Share
AFT	170329 1 Notice Pursuant to Listing rule 7.12.1		62.11KB	Share
AFT	AFT In-Licenses NovaTears® in Australia and New Zealand		134.74KB	Share
AFT	AFT Pharmaceuticals Presentation - Business Update	PRICE SENSITIVE	919.19KB	Share
AFT	RPS SPP Announcement	PRICE SENSITIVE	106.03KB	Share
AFT	DirectorsandOfficersOngoingDisclosureNotice-JB		77.64KB	Share
AFT	Market Update	PRICE SENSITIVE	69.07KB	Share
AFT	Director and senior manager disclosure notice		69.86KB	Share
AFT	2017 New Year Letter to Investors		86.99KB	Share
AFT	AFT Maxigesic License for Nordics with Wiefa		70.73KB	Share
AFT	AFT - Maxiclear now licensed in additional 16 Countries		132.1KB	Share

AFT AFT notes Maxigesic® sales estimates in new market research
23/01/20		113.6KB	Share
AFT Amended Capital Change Notice
17/12/19		135.57KB	Share
AFT Capital Change Notice - Issue of ordinary shares
16/12/19		135.43KB	Share
AFT AFT secures Maxigesic® IV distribution in Indonesia
11/12/19		138.87KB	Share
AFT AFT welcomes new codeine medicine restrictions
05/12/19		157.72KB	Share
AFT Maxigesic to launch in Canada in 2020
26/11/19		148.39KB	Share
AFT Condensed consolidated interim financial statements
21/11/19	PRICE SENSITIVE	307.69KB	Share
AFT AFT earnings rise in line with guidance
21/11/19	PRICE SENSITIVE	296.58KB	Share
AFT AFT signs agreements to new markets worth more than US$1bil
18/11/19		174.16KB	Share
AFT AFT to book one-off non-cash gain on Pascomer® assets
04/11/19	PRICE SENSITIVE	117.44KB	Share
AFT AFT to announce half year results on Nov 21 '19
11/10/19		96.15KB	Share
AFT AFT and SETEK sign medicinal cannabis MoU
08/10/19		175.7KB	Share
AFT Amended Constitution
04/09/19		346.28KB	Share
AFT Annual Meeting Results
02/08/19		235.4KB	Share
AFT Annual Shareholders Meeting Address and Presentation
02/08/19	PRICE SENSITIVE	3.03MB	Share
AFT Maxigesic IV registration in Australia
24/07/19		120.36KB	Share
AFT AFT Licensing Agreement for Pascomer® in North America
05/07/19	PRICE SENSITIVE	158.36KB	Share
AFT Notice of Annual Meeting of Shareholders 2019
03/07/19		282.56KB	Share
AFT AFT Pharmaceuticals’ completes first deal in South America
20/06/19		145.41KB	Share
AFT Annual Meeting and Closing Date for Director Nominations
04/06/19		145.29KB	Share
AFT FY2019 Annual Report
22/05/19	PRICE SENSITIVE	3.51MB	Share
AFT AFT Pharmaceuticals establishes new borrowing facilities
22/05/19	PRICE SENSITIVE	120.95KB	Share
AFT AFT Pharmaceuticals poised for strong earnings growth
22/05/19	PRICE SENSITIVE	157.27KB	Share
AFT AFT results announcement May 22 2019
02/05/19		151.65KB	Share
AFT Clarification
23/04/19		179.89KB	Share
AFT AFT Pharmaceuticals’ completes another 3 deals
12/04/19		495.25KB	Share
AFT Transition to new NZX listing rules wef 1 April 2019
18/03/19		79.23KB	Share
AFT AFT Completes Successful Development of Maxigesic Rapid
01/03/19		111.25KB	Share
AFT 2019 New Year Letter to Investors
20/02/19		120.62KB	Share
AFT Waiver from NZX Main Board Listing Rule 5.2.3
17/12/18		396.31KB	Share
AFT Ongoing Disclosure Notice
14/12/18		65.48KB	Share
AFT New trial of MAXIGESIC® pain relief published in major int
03/12/18		133.85KB	Share
AFT narrative correct on page 18 of the Interim Report
23/11/18		452.37KB	Share
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2018
22/11/18	PRICE SENSITIVE	224.01KB	Share
AFT AFT starts to license Maxigesic IV with deal in South Korea
06/11/18		88.86KB	Share
AFT AFT to announce half year results on Thursday Nov 22 2018
12/10/18		24.22KB	Share
AFT Maxigesic is now licensed in the Russian Federation
28/09/18	PRICE SENSITIVE	50.61KB	Share
AFT section 297(2) 298(2) Directors Interests
22/08/18		60.02KB	Share
AFT AFT Annual Meeting Results 2018
03/08/18		255.21KB	Share
AFT AFT Annual Meeting 2018 Presentation
03/08/18	PRICE SENSITIVE	661.78KB	Share
AFT Chairman's Address at AFT Annual Meeting
03/08/18	PRICE SENSITIVE	298.42KB	Share
AFT Meeting of Shareholders 2018 proxy
05/07/18		133.21KB	Share
AFT Notice of Annual Meeting of Shareholders 2018
05/07/18		265.2KB	Share
AFT Annual Report
19/06/18	PRICE SENSITIVE	3.73MB	Share
AFT NOTICE PURSUANT TO LISTING RULE 7.12.1
15/06/18		63.8KB	Share
AFT Annual Report FY2018
15/06/18	PRICE SENSITIVE	3.73MB	Share
AFT Annual Meeting and Closing Date for Director Nominations
31/05/18		105.8KB	Share
AFT AFT FY2018 Results Announcement
23/05/18	PRICE SENSITIVE	165.65KB	Share
AFT AFT Pharmaceuticals Update
30/04/18		22.82KB	Share
AFT AFT Divests Non-Core Products to Focus on Key Products
21/03/18	PRICE SENSITIVE	120.99KB	Share
AFT Maxigesic hits No. 1 in key Australian painkiller marke
05/03/18		112.35KB	Share
AFT Notice to shareholders – Change of auditor
02/02/18		38.29KB	Share
AFT Prescription-only codeine medicines in New Zealand welcomed
18/01/18		46.05KB	Share
AFT AFT painkiller Maxigesic now licensed in Mexico
27/12/17		45.71KB	Share
AFT Waiver from NZX Main Board Listing Rule 5.2.3
20/12/17		266.16KB	Share
AFT FY2018 H1 Updated Presentation
24/11/17		2.3MB	Share
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2017
23/11/17	PRICE SENSITIVE	168.32KB	Share
AFT Results for announcement to the market App1
23/11/17	PRICE SENSITIVE	107.46KB	Share
AFT Interim Report FY2018
23/11/17	PRICE SENSITIVE	852.02KB	Share
AFT FY2018 H1 Update Presentation
23/11/17	PRICE SENSITIVE	2.3MB	Share
AFT to announce half year results on Thursday November 23 2017
16/10/17		25.05KB	Share
AFT Positive result from large US clinical trial for Maxigesic
12/10/17		50.01KB	Share
AFT 170929 Market Update
29/09/17		34.34KB	Share
AFT 170928 AFT Pharmaceuticals Presentation ASX
29/09/17		2.27MB	Share
AFT AFT Pharmaceuticals celebrates 20 years of success
01/09/17		49.81KB	Share
AFT NZSA presentation
21/08/17		2.45MB	Share
AFT AFT supports Commerce Commission recommendations
17/08/17		43.68KB	Share
AFT Resignation of Head of International Business and Business
08/08/17		51.68KB	Share
AFT Annual Meeting Results 2017
04/08/17		39.87KB	Share
AFT 2017 Annual Meeting Presentations
04/08/17	PRICE SENSITIVE	64.39KB	Share
AFT AFTpainkiller Maxigesic now licensed in 124 countries
20/07/17		71.66KB	Share
AFT AFT Notice of Annual Meeting of Shareholders 2017
11/07/17		409.44KB	Share
AFT D&O Ongoing Disclosure for James Burns
11/07/17		70.04KB	Share
AFT D&O Ongoing Disclosure for James Burns
07/07/17		94.51KB	Share
AFT AFT SPP 7.12.1 Notice
19/06/17		71.65KB	Share
AFT D&O Ongoing Disclosure - multiple Directors
19/06/17		68.5KB	Share
AFT Successful share purchase plan for AFT Pharmaceuticals
14/06/17		94.41KB	Share
AFT s 209 notice
13/06/17		285.73KB	Share
AFT Issue of Annual Report to security holders
12/06/17	PRICE SENSITIVE	1.78MB	Share
AFT Annual Meeting and Closing Date for Director Nominations
01/06/17		105.58KB	Share
AFT Ongoing Disclosure Notice - John Douglas Wilson
25/05/17		67.54KB	Share
AFT SPH Notice - AFT Pharmaceuticals Limited
25/05/17		17.85KB	Share
AFT Share Purchase Plan Opens
24/05/17	PRICE SENSITIVE	98.9KB	Share
AFT Cleansing Notice
24/05/17		42.66KB	Share
AFT AFT FY2017 Results Announcement
24/05/17	PRICE SENSITIVE	203.17KB	Share
AFT Maxigesic now licensed in France
22/05/17	PRICE SENSITIVE	47.69KB	Share
AFT Further European approvals for Maxigesic
19/05/17		49.77KB	Share
AFT Maxigesic on track to access the large United States market
12/05/17		99.77KB	Share
AFT AFT Pharm to announce full year on Wednesday May 24
09/05/17		24.85KB	Share
AFT AFT Pharmaceuticals Presentation - Woodward partners NZ mid
12/04/17		946.78KB	Share
AFT 170329 1 Notice Pursuant to Listing rule 7.12.1
30/03/17		62.11KB	Share
AFT AFT In-Licenses NovaTears® in Australia and New Zealand
21/03/17		134.74KB	Share
AFT AFT Pharmaceuticals Presentation - Business Update
17/03/17	PRICE SENSITIVE	919.19KB	Share
AFT RPS SPP Announcement
17/03/17	PRICE SENSITIVE	106.03KB	Share
AFT DirectorsandOfficersOngoingDisclosureNotice-JB
01/03/17		77.64KB	Share
AFT Market Update
17/02/17	PRICE SENSITIVE	69.07KB	Share
AFT Director and senior manager disclosure notice
20/01/17		69.86KB	Share
AFT 2017 New Year Letter to Investors
16/01/17		86.99KB	Share
AFT AFT Maxigesic License for Nordics with Wiefa
12/01/17		70.73KB	Share
AFT AFT - Maxiclear now licensed in additional 16 Countries
28/12/16		132.1KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.77		Change 0.020(0.73%)		Mkt cap ! n/a

Open	High	Low	Value	Volume
$2.77	$2.77	$2.77	$2.576K	930

Buyers (Bids)

No.	Vol.	Price($)
0	37	$2.70

Sellers (Offers)

Price($)	Vol.	No.
$2.77	564	0

Last trade - 05.59am 01/09/2025 (20 minute delay)

AFT (NZSX) Chart

AFT Pharmaceuticals Limited - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available